|Bid||6.67 x 1800|
|Ask||6.68 x 2200|
|Day's Range||6.61 - 6.70|
|52 Week Range||6.04 - 25.10|
|Beta (3Y Monthly)||3.77|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Here is why it's still not the right time to buy marijuana stocks, such as Aurora Cannabis Inc.(TSX:ACB)(NYSE:ACB), even after a major correction of 2019.
Cannabis stocks just went on sale. If you want to capitalize, stick with pot companies like Green Organic Dutchman Holdings Ltd (TSX:TGOD) and Cronos Group (TSX:CRON)(NASDAQ:CRON).
Hunting for a bargain? This group of beaten-down stocks, including Kirkland Gold (TSX:KL)(NYSE:KL), might provide the value you're looking for.
Altria Group Inc (NYSE:MO) just upped its stake in Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON). That's a huge vote of confidence during the cannabis bear market.
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Top cannabis players have lost 75% in market value over the last year. Here's why investors can expect weakness to continue in the short-term.
Investing.com – Canopy Growth has plunged in recent months to levels that finally make it worth buying, Bank of America said on Wednesday, sending shares of the Canadian cannabis producer sharply higher.
Marijuana stock Cronos Group (TSX:CRON)(NASDAQ:CRON) is undergoing massive transformation. You need to know these coming changes.
TORONTO — Cannabis company Cronos Group Inc. reported a profit in its third quarter, boosted by an $835-million gain in derivative liabilities, as revenue grew to $12.7 million.The company says its net profit amounted to $788 million or 53 cents per diluted share for the quarter ended Sept. 30. That compared with a loss of $7.3 million or four cents per share in the same quarter last year.Cronos says its adjusted earnings before interest, taxes, depreciation and amoritization amounted to a loss of $23.9 million in its most recent quarter compared with a loss of $3.2 million a year ago.Revenue was up from $3.8 million in the same quarter last year and up from $10.2 million in the second quarter of 2019.Analysts had expected Cronos to report $14.1 million in revenue for its third quarter, according to financial markets data firm Refinitiv.Cronos says it sold 3,142 kilograms of cannabis in Canada in the quarter, up from 514 kilograms in the third quarter last year and 1,584 kilograms in the second quarter of 2019.This report by The Canadian Press was first published Nov. 12, 2019.Companies in this story: (TSX:CRON) The Canadian Press
Here’s what you need to know about Cronos Group’s (TSX:CRON)(NASDAQ:CRON) latest quarterly financial results.
All eyes will be on President Trump Tuesday for U.S.-China trade war updates. Walmart, Nvidia, and others are set to report their quarterly earnings. And why Casey's General Stores (CASY) is a Zacks Rank 1 (Strong Buy) right now...
Cronos (CRON) delivered earnings and revenue surprises of 33.33% and -3.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Closed Redwood U.S. Hemp-Based Products Platform and Cronos Fermentation Facility Acquisitions Announced the launch PEACE+™, A New Hemp-Derived U.S. Brand Advanced Operational.
With stocks breaking out to new highs, many investors are wondering whether this rally can last through the end of the year. TG Watkins, the Director of Stocks at Simpler Trading, thinks small caps are even breaking out which is a clear sign that this rally has legs. Even more, one particular sector he likes is cannabis, which might be getting ready to finally reverse course as The MORE Act removes the marijuana plant from the federal Controlled Substances Act.